Bionovate Technologies Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	2016 - 2012
Period Ending	Mar '26 Mar 6, 2026	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019	Jun '18 Jun 30, 2018	Jun '17 Jun 30, 2017	2016 - 2012
Market Capitalization	0	20	59	1	9	1	Upgrade
Market Cap Growth	-100.00%	-67.06%	6256.95%	-89.29%	606.18%	53.43%	Upgrade
Enterprise Value	-	20	60	1	9	1	Upgrade
Last Close Price	0.00	0.95	1.00	6.00	56.00	412.65	Upgrade
PS Ratio	-	-	-	-	-	229.39	Upgrade
PB Ratio	0.00	-38.90	-149.81	-2.81	-28.17	-5.39	Upgrade
P/OCF Ratio	-	-	-	-	-	116.51	Upgrade
EV/Sales Ratio	-	-	-	-	-	227.52	Upgrade
Debt / Equity Ratio	-0.53	-0.55	-0.57	-0.68	-0.87	-0.19	Upgrade
Net Debt / Equity Ratio	-0.53	-0.55	-0.57	-0.68	-0.87	-0.19	Upgrade
Return on Capital Employed (ROCE)	9.20%	9.00%	8.30%	17.00%	38.40%	38.30%	Upgrade
Earnings Yield	-1316325.00%	-0.54%	-0.21%	-22.35%	-19.95%	-26.17%	Upgrade
Buyback Yield / Dilution	80.53%	68.98%	-15943.66%	-145.73%	-	-	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.